The FDA has licensed Sanofi Pasteur’s H5N1 vaccine, the first avian flu vaccine for humans. Sanofi Pasteur, in collaboration with the National Institutes of Health, submitted a BLA to the FDA for the vaccine. The licensure is the first step in achieving the government’s goal of stockpiling vaccine to protect those who are at increased risk of exposure to the H5N1 flu virus contained in the vaccine during the early stages of a pandemic. “The licensure of the nation’s ...